Posted on 04/28/2021 8:07:49 AM PDT by SeekAndFind
* Pfizer’s experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.
* The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.
* Protease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C.
Pfizer’s experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.
The company, which developed the first authorized Covid-19 vaccine in the U.S. with German drugmaker BioNTech, began in March an early stage clinical trial testing a new antiviral therapy for the disease. The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.
Protease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C.
If clinical trials go well and the Food and Drug Administration approves it, the drug could be distributed across the U.S. by the end of the year, Bourla told CNBC’s “Squawk Box.”
Health experts say the drug, taken by mouth, could be a game changer because people newly infected with the virus could use it outside of hospitals. Researchers hope the medication will keep the disease from progressing and prevent hospital trips.
In addition to the drug, Pfizer is still testing its vaccine in 6-month to 11-year-old children. Vaccinating children is crucial to ending the coronavirus pandemic, public health officials and infectious disease experts say.
(Excerpt) Read more at cnbc.com ...
.
General Jack T. Ripper knew all about that!
Are you saying we might finally have a cure for the common cold after all these drippy red-eyed thousands of years?
RE: expensive form of Ivermectin
Yes, it looks like it. See here for Ivermectin’s mechanism against SARS-COV-2 :
Along with some Vitamin D, Zinc and a little bit of HCQ thrown in so it qualifies as a "new" drug and thus can cost hundreds of dollars per dose.
Unfortunately, coronaviruses on account for about 1/5th of common colds. But rhinoviruses and RSV’s are also susceptible to protease inhibitors, so maybe a cocktail would work, since you won’t know which you have. But it might cost $1,000 to get rid of a cold and never mind the side effects, whatever they are.
So easy to make money when you pals are running the FDA.
Hippocratic oath: First, do no harm to drug company profits.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.